This is the authors' abstract. We don't add key points for this paper.
Macrolides are inappropriate as first-choice agents against MRMP in terms of shortening the clinical course and decreasing M. pneumoniae. Control and prevention of MRMP outbreaks in children require early decreases in M. pneumoniae as well as improvement of clinical findings.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Okada et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: